Basic Information
Basic information for SNHG14-278-12aa-4
Peptide Name SNHG14-278-12aa-4
Genome Position chr15:25119960-25119995[+]
Species Human
Peptide Sequence MWLTTLSSNGNE
Peptide Length 12
Unique No (SNHG14-210-12aa-8,SNHG14-223-12aa-2,SNHG14-224-12aa-12,SNHG14-227-12aa-3,SNHG14-230-12aa-2,SNHG14-231-12aa-5,SNHG14-232-12aa-1,SNHG14-235-12aa-2,SNHG14-236-12aa-1,SNHG14-239-12aa-3,SNHG14-242-12aa-4,SNHG14-248-12aa-3,SNHG14-249-12aa-1,SNHG14-251-12aa-1,SNHG14-254-12aa-1,SNHG14-255-12aa-1,SNHG14-257-12aa-2,SNHG14-268-12aa-2,SNHG14-269-12aa-2,SNHG14-270-12aa-3,SNHG14-274-12aa-4,SNHG14-275-12aa-3,SNHG14-276-12aa-2,SNHG14-277-12aa-1,SNHG14-279-12aa-2,SNHG14-280-12aa-2,SNHG14-281-12aa-2,SNHG14-282-12aa-3,SNHG14-283-12aa-3,SNHG14-287-12aa-3,SNHG14-288-12aa-2,SNHG14-293-12aa-3,SNHG14-298-12aa-1,SNHG14-300-12aa-2,SNHG14-301-12aa-2,SNHG14-304-12aa-4,SNHG14-309-12aa-4,SNHG14-311-12aa-1,SNHG14-312-12aa-3,SNHG14-313-12aa-2,SNHG14-314-12aa-2,SNHG14-321-12aa-1,SNHG14-322-12aa-2,SNHG14-323-12aa-3,SNHG14-324-12aa-2,SNHG14-325-12aa-1,SNHG14-330-12aa-3,SNHG14-332-12aa-1,SNHG14-333-12aa-1,SNHG14-334-12aa-3,SNHG14-335-12aa-1,SNHG14-338-12aa-4,SNHG14-340-12aa-4)
Grand Average of Hydropathicity -0.4417
Relative Molecular Mass 1550.71
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000661889;SNHG14-278
Transcript Length 7640
Coding Ability 0.4479
DNA Sequence Corresponding to Peptide ATGTGGTTAACAACTTTATCTTCAAATGGCAATGAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :